Even the CEOs of Big Pharmas have come under fire. Activist investor Starboard Value has made no secret of its criticism of Pfizer CEO Albert Bourla’s track record, while GSK CEO Emma Walmsley fought ...

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...

"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...

Arbele Limited, a Hong Kong-based biotech company, was awarded first place at the 4th Biomedical Pitch Competition, hosted by the Boston Capital Investment Club (BCIC). Selected from over 170 ...

China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency. See ...

Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...

Catalio Capital Management announced the closing of its more than $400 million Fund IV. The fund will continue the firm’s ...

The EC received a total of 76 expressions of interest proposing to set up AI gigafactories in 16 member states across 60 ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by ...

Coinbase tends to perform well during periods of high crypto trading activity, but its earnings are highly sensitive to ...